R
Ronald A. Thisted
Researcher at University of Chicago
Publications - 161
Citations - 19568
Ronald A. Thisted is an academic researcher from University of Chicago. The author has contributed to research in topics: Population & Computational statistics. The author has an hindex of 65, co-authored 161 publications receiving 17943 citations. Previous affiliations of Ronald A. Thisted include University of Texas MD Anderson Cancer Center & University of Illinois at Chicago.
Papers
More filters
Journal ArticleDOI
Loneliness as a specific risk factor for depressive symptoms: Cross-sectional and longitudinal analyses.
TL;DR: It is suggested that loneliness and depressive symptomatology can act in a synergistic effect to diminish well-being in middle-aged and older adults.
Journal ArticleDOI
Sleep and Psychiatric Disorders: A Meta-analysis
TL;DR: Although no single sleep variable appeared to have absolute specificity for any particular psychiatric disorder, patterns of sleep disturbances associated with categories of psychiatric illnesses were observed.
Journal ArticleDOI
Perceived social isolation makes me sad: 5-year cross-lagged analyses of loneliness and depressive symptomatology in the Chicago Health, Aging, and Social Relations Study.
TL;DR: Cross-lagged analyses indicated that loneliness predicted subsequent changes in depressive symptomatology, but not vice versa, and that this temporal association was not attributable to demographic variables, objective social isolation, dispositional negativity, stress, or social support.
Journal ArticleDOI
Not all patients want to participate in decision making. A national study of public preferences.
TL;DR: It is demonstrated that people vary substantially in their preferences for participation in decision making and Physicians and health care organizations should not assume that patients wish to participate in clinical decision making, but must assess individual patient preferences and tailor care accordingly.
Journal ArticleDOI
Results of Conservative Management of Clinically Localized Prostate Cancer
Gerald W. Chodak,Ronald A. Thisted,Glenn S. Gerber,Jan-Erik Johansson,Jan Adolfsson,George W. Jones,Geoff D. Chisholm,Boaz Moskovitz,Pinhas M. Livne,John J. Warner +9 more
TL;DR: The strategy of initial conservative management and delayed hormone therapy is a reasonable choice for some men with grade 1 or 2 clinically localized prostate cancer, particularly for those who have an average life expectancy of 10 years or less.